Murphy, Brandon M.
Terrell, Elizabeth M.
Chirasani, Venkat R.
Weiss, Tirzah J.
Lew, Rachel E.
Holderbaum, Andrea M. https://orcid.org/0000-0002-8911-0550
Dhakal, Aastha
Posada, Valentina
Fort, Marie
Bodnar, Michael S.
Carey, Leiah M.
Chen, Min
Burd, Craig J.
Coppola, Vincenzo https://orcid.org/0000-0001-6163-1779
Morrison, Deborah K. https://orcid.org/0000-0002-1928-1987
Campbell, Sharon L. https://orcid.org/0000-0003-0311-409X
Burd, Christin E. https://orcid.org/0000-0002-7919-3954
Funding for this research was provided by:
Damon Runyon Cancer Research Foundation (38-16)
Foundation for the National Institutes of Health (P30 CA016058)
Foundation for the National Institutes of Health (F31 CA236418)
Foundation for the National Institutes of Health (T32 GM068412)
American Cancer Society (PF-20-140-01-CDD)
Article History
Received: 4 January 2021
Accepted: 24 May 2022
First Online: 7 June 2022
Competing interests
: C.E.B. and B.M.M. are inventors of TN61 cell lines licensed to Millipore. All other authors declare no competing interests.